[HTML][HTML] Aging, cellular senescence, and Alzheimer's disease
RM Liu - International journal of molecular sciences, 2022 - mdpi.com
Aging is the greatest risk factor for late-onset Alzheimer's disease (LOAD), which accounts
for> 95% of Alzheimer's disease (AD) cases. The mechanism underlying the aging-related …
for> 95% of Alzheimer's disease (AD) cases. The mechanism underlying the aging-related …
[HTML][HTML] Revisiting the grammar of Tau aggregation and pathology formation: how new insights from brain pathology are shaping how we study and target …
G Limorenko, HA Lashuel - Chemical Society Reviews, 2022 - pubs.rsc.org
Converging evidence continues to point towards Tau aggregation and pathology formation
as central events in the pathogenesis of Alzheimer's disease and other Tauopathies …
as central events in the pathogenesis of Alzheimer's disease and other Tauopathies …
Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease
Alzheimer's disease (AD) causes unrelenting, progressive cognitive impairments, but its
course is heterogeneous, with a broad range of rates of cognitive decline. The spread of tau …
course is heterogeneous, with a broad range of rates of cognitive decline. The spread of tau …
Microglia in Alzheimer's disease
Proliferation and activation of microglia in the brain, concentrated around amyloid plaques,
is a prominent feature of Alzheimer's disease (AD). Human genetics data point to a key role …
is a prominent feature of Alzheimer's disease (AD). Human genetics data point to a key role …
[HTML][HTML] Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology
SH Lee, WJ Meilandt, L Xie, VD Gandham, H Ngu… - Neuron, 2021 - cell.com
Loss-of-function TREM2 mutations strongly increase Alzheimer's disease (AD) risk. Trem2
deletion has revealed protective Trem2 functions in preclinical models of β-amyloidosis, a …
deletion has revealed protective Trem2 functions in preclinical models of β-amyloidosis, a …
[HTML][HTML] New insights into the role of TREM2 in Alzheimer's disease
Alzheimer's disease (AD) is the leading cause of dementia. The two histopathological
markers of AD are amyloid plaques composed of the amyloid-β (Aβ) peptide, and …
markers of AD are amyloid plaques composed of the amyloid-β (Aβ) peptide, and …
[HTML][HTML] Roles of tau protein in health and disease
Tau is well established as a microtubule-associated protein in neurons. However, under
pathological conditions, aberrant assembly of tau into insoluble aggregates is accompanied …
pathological conditions, aberrant assembly of tau into insoluble aggregates is accompanied …
Alzheimer's disease: experimental models and reality
E Drummond, T Wisniewski - Acta neuropathologica, 2017 - Springer
Experimental models of Alzheimer's disease (AD) are critical to gaining a better
understanding of pathogenesis and to assess the potential of novel therapeutic approaches …
understanding of pathogenesis and to assess the potential of novel therapeutic approaches …
[HTML][HTML] Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer's disease and frontotemporal dementia
Aging, pathological tau oligomers (TauO), and chronic inflammation in the brain play a
central role in tauopathies, including Alzheimer's disease (AD) and frontotemporal dementia …
central role in tauopathies, including Alzheimer's disease (AD) and frontotemporal dementia …
Rodent models for Alzheimer disease
Animal models are indispensable tools for Alzheimer disease (AD) research. Over the
course of more than two decades, an increasing number of complementary rodent models …
course of more than two decades, an increasing number of complementary rodent models …